India, April 7 -- The global healthcare industry is currently caught in the crossfire of a high-stakes 'weight loss drug war'. The demand for miracle jabs and pills has turned life-saving medication into a trending formula. The use of semaglutide, which belongs to a group of drugs called GLP-1 receptor agonists and is prescribed for type 2 diabetes and weight management, is on the rise, especially with the increasing access to generic versions at lower prices. In India, where at least 25 per cent of adults are overweight or obese, doctors are highlighting how the promise of a "quick fix" clashes with the grim reality of likely medical misuse.

For World Health Day 2026, Health Shots interviewed Dr V. Mohan, one of the country's leading v...